Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)

被引:57
作者
Han, Young Taek [1 ]
Kim, Kyeojin [2 ]
Choi, Gyeong-In [2 ]
An, Hongchan [2 ]
Son, Dohyun [3 ]
Kim, Hee [4 ]
Ha, Hee-Jin [4 ]
Son, Jun-Hyeng [2 ]
Chung, Suk-Jae [2 ]
Park, Hyun-Ju [3 ]
Lee, Jeewoo [2 ]
Suh, Young-Ger [2 ]
机构
[1] Woosuk Univ, Coll Pharm, Wonju 565701, South Korea
[2] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[3] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea
[4] Medifron DBT, Ansan 425839, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
RAGE (receptor for advanced glycation end products); Alzheimer's disease; RAGE inhibitor; Pyrazole-5-carboxamide; SAR (structure activity relationship); ALZHEIMERS-DISEASE; AMYLOID-BETA; CRYSTAL-STRUCTURE; KAPPA-B; PYRAZOLES; ACTIVATION; CLEARANCE; PROGRESS; PEPTIDE; BRAIN;
D O I
10.1016/j.ejmech.2014.03.072
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In an effort to develop novel inhibitors of receptor for advanced glycation end products (RAGE) for the treatment of Alzheimer's disease, a series of pyrazole-5-carboxamides were designed, synthesized and biologically evaluated. Analyses of the extensive structure activity relationship (SAR) led us to identify a 4-fluorophenoxy analog (40) that exhibited improved in vitro RAGE inhibitory activity and more favorable aqueous solubility than the parent 2-aminopyrimidine, 1. Surface plasmon resonance (SPR) and molecular docking study strongly supported the RAGE inhibitory activity of pyrazole-5-carboxamides. The brain A beta-lowering effect of 40 is also described. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:128 / 142
页数:15
相关论文
共 39 条
[1]   Current Therapies and New Strategies for the Management of Alzheimer's Disease [J].
Aderinwale, Olapeju G. ;
Ernst, Hans W. ;
Mousa, Shaker A. .
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (05) :414-424
[2]  
[Anonymous], 2011, SYBYL MOL MOD SOFTW
[3]  
Benchware&REG, 2011, BENCHW 3D EXPL 3D CH
[4]   Self-assembly of NH-pyrazoles via intermolecular N-H•••N hydrogen bonds [J].
Bertolasi, V ;
Gilli, P ;
Ferretti, V ;
Gilli, G ;
Fernàndez-Castaño, C .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 1999, 55 :985-993
[5]   A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates [J].
Bevan, CD ;
Lloyd, RS .
ANALYTICAL CHEMISTRY, 2000, 72 (08) :1781-1787
[6]   Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].
Bierhaus, A ;
Schiekofer, S ;
Schwaninger, M ;
Andrassy, M ;
Humpert, PM ;
Chen, J ;
Hong, M ;
Luther, T ;
Henle, T ;
Klöting, I ;
Morcos, M ;
Hofmann, M ;
Tritschler, H ;
Weigle, B ;
Kasper, M ;
Smith, M ;
Perry, G ;
Schmidt, AM ;
Stern, DM ;
Häring, HU ;
Schleicher, E ;
Nawroth, PP .
DIABETES, 2001, 50 (12) :2792-2808
[7]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[8]   Fluorine in medicinal chemistry [J].
Böhm, HJ ;
Banner, D ;
Bendels, S ;
Kansy, M ;
Kuhn, B ;
Müller, K ;
Obst-Sander, U ;
Stahl, M .
CHEMBIOCHEM, 2004, 5 (05) :637-643
[9]   1,3-Dipolar Cycloaddition of Nitrile Imines with Functionalized Acetylenes: Regiocontrolled Sc(OTf)3-Catalyzed Synthesis of 4-and 5-Substituted Pyrazoles [J].
Bonini, Bianca Flavia ;
Franchini, Mauro Comes ;
Gentili, Denis ;
Locatelli, Erika ;
Ricci, Alfredo .
SYNLETT, 2009, (14) :2328-2332
[10]   RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain [J].
Deane, R ;
Yan, SD ;
Submamaryan, RK ;
LaRue, B ;
Jovanovic, S ;
Hogg, E ;
Welch, D ;
Manness, L ;
Lin, C ;
Yu, J ;
Zhu, H ;
Ghiso, J ;
Frangione, B ;
Stern, A ;
Schmidt, AM ;
Armstrong, DL ;
Arnold, B ;
Liliensiek, B ;
Nawroth, P ;
Hofman, F ;
Kindy, M ;
Stern, D ;
Zlokovic, B .
NATURE MEDICINE, 2003, 9 (07) :907-913